Dose Response Relations for Health Effects Caused by Office Dust
|ClinicalTrials.gov Identifier: NCT00143637|
Recruitment Status : Completed
First Posted : September 2, 2005
Last Update Posted : March 27, 2008
The study is focused at the dose response relation for office dust and such office dust spiked with components from fungi known from damp buildings.
The first aim of this study is to investigate if dust causes objective changes such as changes of lung function, nasal geometry, inflammatory indicators in tears and nasal lavage, tear film stability and cells at exposure levels relevant to indoor air. The controlled exposure variable is air concentration of office dust spiked with Glucan to simulate a worse case scenario.
Aim 1: Confirm or support the causality between objective effects and exposures to dust spiked with Glucan with focus on inflammatory responses. This is done by negation of the hypothesis that no significant effects are found for the variables in question.
Aim 2 is to estimate the thresholds and slopes of the DR relation for effect measures which show effects of exposures. At best the study will supply for each variable a zero response to clean air and three non-zero responses to dust. Thresholds and slopes are estimated graphically by linear regression or by an accumulated response model.
Aim 3 is a confirmation that atopic persons and histamine sensitive persons in nasal provocation tests have different responses in the effect measures showing significant effects of exposures to dust spiked with Glucan. Risk group status is therefore included in the analyses of the main variables as explaining variable.
Potential additional aim 4: Chemical and biological characterization of the office dust used in the study.
Aim 4 is an investigation of dose response relations for explorative measures, which in previous investigations have showed indications of a dose response relation. For these no a priory hypotheses exists and the analyses must be arranged ad hoc. The explaining variables are exposure and risk group status.
One challenge in investigations of unspecific effects caused by mixed exposures is that few specific objective effects measures are available and subjective measures have to be introduced. Therefore there is a need for developments of new objective measures of health effects of air pollution. Some of these are related to new biomarkers of respiratory effects in a bio-sample taken as condensed exhaled breath.
Aim 5: Developments of new objective measures of health effects of air pollution. After the experiment it will be investigated by logistic regression if a sensitivity index can be established.
|Condition or disease||Intervention/treatment||Phase|
|Discomfort Symptoms Changed Lung Function||Other: Office dust Other: clean air||Phase 1 Phase 2|
The basic procedure is an exposure experiment in which human subjects are exposed to controlled variations of dust spiked with Glucan. Their responses are monitored before, after minutes and hours of exposure and later the same evening.
Two groups of subjects are selected in a pre-investigation using strict selection and exclusion criteria. The two groups are atopic persons and responders to Histamine in a RSM nasal provocation test.
The groups are exposed under controlled conditions in a climate chamber at IMA to office dust spiked with Glucan (same procedure and amount as in DAMOS) at clean air level (less than 20 micro-g/m3 (TSP) and at 150, 300 and 700 micro-g/m3 (TSP). In the pre-investigation and during the exposure sessions a number of personal characteristics are measured or registered to be used in the statistical analyses as explaining variables for the responses of the subjects.
The dust exposure will be characterized both though its size distribution and gravimetrically using up-to-date analytical instruments. To optimise the exposures several pilot studies are made. Only effects measures, which previously have shown clear indications of responses to dust exposures, are included in the study.
The timetable includes pre-investigations, two repetitions of the exposure design (run 1 and 2), analyses of the bio-samples, statistical analyses, and reporting.
The study includes a main study and several additional work-packages, which will be activated when funding become available.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||24 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Dose Response Relations for Health Effects Caused by Office Dust.|
|Study Start Date :||May 2005|
|Primary Completion Date :||November 2006|
|Study Completion Date :||November 2006|
Office dust with added glucan
Other: Office dust
airborne office dust spiked with glucan
Other Name: Glucan
Clean air exposures in climate chamber
Other: clean air
- Lung Inflammation [ Time Frame: during exposures ]
- Lung function [ Time Frame: during exposures ]
- FEV [ Time Frame: during exposures ]
- FVC [ Time Frame: during exposures ]
- Acoustic rhinometry [ Time Frame: during exposures ]
- cytokine profile [ Time Frame: during exposures ]
- Peak expiratory flow [ Time Frame: during exposures ]
- inflammation and sensory symptoms [ Time Frame: during exposures ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00143637
|The Air Pollution Unit, Department of Environmental and Occupational Medicine, Institute of Public Health, The University of Aarhus.|
|Aarhus, Denmark, DK-8000|
|Principal Investigator:||Lars Mølhave, DMSc, Ph.D.||The Air Pollution Unit, Department of Environmental and Occupational Medicine, Institute of Public Health, The University of Aarhus.|